Evidence map›Paper›PMID 42402535›Full record

ArticleInternational journal of hematology2026

Modified short-course fludarabine-based conditioning regimen for salvage cord blood transplantation after graft failure.

Toshimitsu Ueki, Shigeo Fuji, Motohiro Kato, Ritsuro Suzuki, Masao Ogata, Yumiko Maruyama, Emiko Sakaida, Shuichi Shirane, Masako Toyosaki, Nobuhiro Hiramoto and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Toshimitsu UekiDepartment of Hematology, Japanese Red Cross Nagano Hospital, Nagano, 380-8582, Japan. toshimitsu-u@h9.dion.ne.jp.ORCID http://orcid.org/0000-0002-2316-8303
Shigeo FujiDepartment of Hematology, Osaka International Cancer Institute, Osaka, Japan.
Motohiro KatoDepartment of Pediatrics, The University of Tokyo, Tokyo, Japan.
Ritsuro SuzukiDepartment of Oncology and Hematology, Shimane University Hospital, Izumo, Japan.
Masao OgataDepartment of Hematology, Oita University Hospital, Oita, Japan.
Yumiko MaruyamaDepartment of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Emiko SakaidaDepartment of Hematology, Chiba University Hospital, Chiba, Japan.
Shuichi ShiraneDepartment of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Masako ToyosakiDepartment of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Koji NagafujiDivision of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Japan.
Naoyuki UchidaDepartment of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Yasufumi UeharaDepartment of Hematology, Kitakyushu City Hospital Organization,, Kitakyushu Municipal Medical Center, Kitakyushu, Japan.
Shingo YanoClinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
Takafumi KimuraJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Yoshiko AtsutaJapanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.
Takahiro FukudaDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Transplant Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graft failure after allogeneic hematopoietic stem cell transplantation is a life-threatening complication requiring retransplantation. Cord blood is frequently used in this setting, although the optimal conditioning regimen remains unclear. Recently, a modified short-course fludarabine-based conditioning regimen has been used in clinical practice for salvage cord blood retransplantation in Japan.Using Japanese registry data, we analyzed 465 patients with hematologic malignancies who developed graft failure and underwent cord blood retransplantation within 2 months after allogeneic hematopoietic stem cell transplantation between 2008 and 2016. Of these, 84 patients received a modified short-course fludarabine-based conditioning regimen consisting of fludarabine 30 to 90 mg/m

Indexed as

1-day conditioning regimenCord blood transplantationGraft failureHematopoietic stem cell transplantationShort-course conditioning regimen

Identifiers

PMID42402535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.